Endothelial progenitor cells in non-Hodgkin's lymphoma

Haematologica

Volumn 92, Issue 4, 2007, Pages 433-434

  Oki, Yasuhiro ^a   Younes, Anas ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SAMPLING; CANCER PATIENT; CANCER STEM CELL; DISEASE MARKER; EDITORIAL; ENDOTHELIUM CELL; HUMAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PATIENT SELECTION; PREGNANT WOMAN; PROGNOSIS; TUMOR VASCULARIZATION; BLOOD; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; NEOVASCULARIZATION (PATHOLOGY); NOTE; PATHOLOGY; STEM CELL; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITOR;

ANGIOGENESIS INHIBITORS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, NON-HODGKIN; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS;

EID: 34547683711     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11367     Document Type: Editorial

References (21)

1. Dvorak HF. Angiogenesis: update 2005. J Thromb Haemost 2005;3:1835-42.
2. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29 Suppl 16:15-8.
3. Garmy-Susini B, Varner JA. Circulating endothelial progenitor cells. Br J Cancer 2005;93:855-8.
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
5. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-8.
6. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-7.
7. Ribatti D. The involvement of endothelial progenitor cells in tumor angiogenesis. J Cell Mol Med 2004;8:294-300.
8. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002;2:826-35.
9. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-201.
10. Bailey AS, Jiang S, Afentoulis M, Baumann CI, Schroeder DA, Olson SB, et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 2004;103:13-9.
11. Bagley RG, Walter-Yohrling J, Cao X, Weber W, Simons B, Cook BP, et al. Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells. Cancer Res 2003;63:5866-73.
12. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003;107:461-8.
13. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004;109:2692-7.
14. Siepe M, Heilmann C, von Samson P, Menasche P, Beyersdorf F. Stem cell research and cell transplantation for myocardial regeneration. Eur J Cardiothorac Surg 2005; 28: 318-24.
15. Rigolin GM, Fraulini C, Ciccone M, Mauro E, Bugli AM, De Angeli C, et al. Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood 2006; 107: 2531-5.
16. Leibundgut EO, Horn MP, Brunold C, Pfanner-Meyer B, Marti D, Hirsiger H, et al. Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases. Haematologica 2006;91:1465-72.
17. Dentelli P, Rosso A, Balsamo A, Colmenares Benedetto S, Zeoli A, Pegoraro M, et al. c-Kit by interacting with the membrane-bound ligand recruits endothelial progenitor cells to inflamed endothelium. Blood 2007;[Epub ahead of print].
18. Igreja C, Courinha M, Cachaco AS, Pereira T, Cabecadas J, da Silva MG, et al. Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica 2007;92;469-76.
19. Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006;66:7341-7.
20. Zhang H, Vakil V, Braunstein M, Smith EL, Maroney J, Chen L, et al. Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 2005;105:3286-94.
21. Bertolini F, Paul S, Mancuso P, Monestiroli S, Gobbi A, Shaked Y, et al. Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 2003;63:4342-6.